255 results on '"Radziwon P"'
Search Results
52. Behaviorally measured audiograms and gap detection thresholds in CBA/CaJ mice
53. Temporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration.
54. Optimization of TLC Detection by Phosphomolybdic Acid Staining for Robust Quantification of Cholesterol and Bile Acids
55. Decreased levels of PAI-1 and alpha 2-antiplasmin contribute to enhanced fibrinolytic activity in divers
56. Antithrombotic and platelet function inhibiting effects of ML3000, a new antiinflammatory drug with COX/5-LOX inhibitory activity
57. Establishment of the first International Repository for Transfusion-Relevant Bacteria Reference Strains: ISBT Working Party Transfusion-Transmitted Infectious Diseases (WP-TTID), Subgroup on Bacteria
58. Experimental Studies on the Interaction of LW 10082 (Aprosulphate) with Other Antithrombotic Agents in Laser-Induced Thrombosis
59. THE EFFECT OF ADDITIVE SOLUTION ON PLATELET FUNCTION IN PLATELET CONCENTRATES PREPARED USING DIFFERENT METHODS AND STORED OVER 7 DAYS: P-321
60. COMPARISON OF PLATELET CONCENTRATES DURING STORAGE IN ADDITIVE SOLUTION AND PLASMA: P-102
61. THE EFFECTIVENESS OF ERYTHRAPHERESIS PERFORMED WITH BLOOD SEPARATOR MCS+ IN PATIENTS WITH PRIMARY POLYCYTHAEMIA: P-049
62. EVALUATION OF THREE DIFFERENT PROTOCOLS OF PLATELETPHERESIS WITH COM.TEC BLOOD SEPARATOR FOR EFFICACY OF THE PROCEDURE AND QUALITY OF PLATELET CONCENTRATES: P-579
63. Von willebrand factor antigen in assessment of vasculitis in patients with connective tissue diseases
64. The effect of continuous-flow automated plateletpheresis on fibrinolytic activity of donor plasma
65. Ethnical differences in HLA-II genotyping results of North-Eastern Polish ulcerative colitis patients
66. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2
67. IBS Patients’ Treatment Expectancy and Motivation Impacts Quality of the Therapeutic Alliance With Provider
68. Fatty acids and sphingolipids profile in the blood plasma of experienced divers in response to hyperbaric exposure.
69. Open innovation in SMEs: Exploring inter-organizational relationships in an ecosystem.
70. Innovation, entrepreneurial, knowledge, and business ecosystems: Old wine in new bottles?
71. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
72. Efficient Triple Helix collaboration fostering local niche innovation projects – A case from Denmark.
73. Leucoreduction helps to preserve activity of antioxidant barrier enzymes in stored red blood cell concentrates
74. Znaczenie mikrocząstek w transfuzjologii
75. Assessment of diving risks — based on selected haemostatic parameters
76. (Can’t Get No) Patient Satisfaction
77. Methods for detection of microparticles derived from blood and endothelial cells
78. Ocena jakości mrożonych koncentratów krwinek płytkowych zamrażanych w małej objętości roztworu krioochronnego
79. Wpływ fal radiowych generowanych w systemie RIFD na jakość koncentratów płytek krwi
80. Choroideremia
81. Network-based automation for SMEs
82. The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients
83. Establishment of the first International Repository for Transfusion-Relevant Bacteria Reference Strains: ISBT Working Party Transfusion-Transmitted Infectious Diseases (WP-TTID), Subgroup on Bacteria
84. Decreased levels of PAI-1 and alpha2-antiplasmin contribute to enhanced fibrinolytic activity in divers
85. Prevalence of hepatitis C virus antibodies among blood donors in north-eastern Poland
86. Mo1436: IS SYMPTOM REMISSION POSSIBLE WITH PSYCHOSOCIAL TREATMENTS FOR IRRITABLE BOWEL SYNDROME?: RATES OF REMISSION FOR COGNITIVE BEHAVIORAL THERAPY VS EDUCATION/SUPPORT AT IMMEDIATE AND 6 MONTH FOLLOW UP.
87. Mo1431: PREDICTORS OF DROPOUT FROM COGNITIVE BEHAVIOR THERAPY (CBT) FOR IBS: FINDINGS FROM A RANDOMIZED CLINICAL TRIAL.
88. Changes in the extrinsic and intrinsic coagulation pathways in humans after decompression following saturation diving
89. Koncentrat płytek krwi napromieniowany czy poddany redukcji biologicznych czynników chorobotwórczych – który składnik wybrać w celu profilaktyki poprzetoczeniowej choroby przeszczep-przeciw-gospodarzowi?
90. The Effects of Polysulfonate Derivative (GL 2021) on Coagulation in Vitro and Thrombosis in Vivo
91. Platelet activation and its role in thrombin generation in platelet-induced thrombin generation time
92. Anti-counterfeit Solution from Organic Semiconductor.
93. The Smart Factory: Exploring Adaptive and Flexible Manufacturing Solutions.
94. Comparative Study on the In Vitro and In Vivo Activities of Heparinoids Derivative Investigated on the Animal Model
95. Effects of Polysulfonate Derivative (GL 522-Y-1) on Coagulation in vitro and Thrombosis in vivo
96. Effects of a Supersulfated Low Molecular Weight Heparin (IK-SSH) on Different Hemostatic Parameters
97. A Recombinant Hirudin (IK-HIR02) in Healthy Volunteers
98. Combination of LC–MS-and GC–MS-basedMetabolomics to Study the Effect of Ozonated Autohemotherapy on HumanBlood.
99. Platelet-Induced Thrombin Generation Time II (PITT II) A Modified Global Coagulation Test to Monitor Prophylactic Anticoagulation with Vitamin K Antagonists? - A United Kingdom field study of two widely used coagulometers
100. Metabolomic Approach with LC−MS Reveals Significant Effect of Pressure on Diver’s Plasma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.